γ-Aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine
- 28 April 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 395 (2) , 129-135
- https://doi.org/10.1016/s0014-2999(00)00267-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats.Psychopharmacology, 1999
- A pharmacologic strategy for the treatment of nicotine addictionSynapse, 1998
- A novel strategy for the treatment of cocaine addictionSynapse, 1998
- GABAergic attenuation of cocaine-induced dopamine release and locomotor activitySynapse, 1997
- Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1European Journal of Pharmacology: Molecular Pharmacology, 1994
- GABAB‐Receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigraSynapse, 1993
- GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomographyJournal of Neuroscience, 1992
- Inhibition of γ-aminobutyrate and glycine uptake into synaptic vesiclesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- (R)‐N‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake CarrierJournal of Neurochemistry, 1990
- Long‐Term Evaluation of Vigabatrin (Gamma Vinyl GABA) in EpilepsyEpilepsia, 1989